Holen Sie sich die Stockscreener-App
3.14
0.63%
-0.02
Handel nachbörslich:
3.12
-0.02
-0.64%
Schlusskurs vom Vortag:
$3.16
Offen:
$3.15
24-Stunden-Volumen:
1.02M
Relative Volume:
0.84
Marktkapitalisierung:
$1.16B
Einnahmen:
$159.54M
Nettoeinkommen (Verlust:
$5.06M
KGV:
-713.64
EPS:
-0.0044
Netto-Cashflow:
$26.19M
1W Leistung:
+1.29%
1M Leistung:
+14.18%
6M Leistung:
+20.77%
1J Leistung:
+24.60%
1-Tages-Spanne:
$3.045
$3.16
1-Wochen-Bereich:
$2.99
$3.31
52-Wochen-Spanne:
$2.28
$3.43
Cronos Group Inc Stock (CRON) Company Profile
Firmenname
Cronos Group Inc
Sektor
Telefon
(416) 504-0004
Adresse
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRON
Cronos Group Inc
|
3.14 | 1.17B | 159.54M | 5.06M | 26.19M | -0.0044 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-28 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Hochstufung | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-11-18 | Fortgesetzt | BofA Securities | Underperform |
| 2021-04-28 | Fortgesetzt | BofA Securities | Underperform |
| 2021-02-22 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Hochstufung | MKM Partners | Neutral → Buy |
| 2020-03-03 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-18 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-09-05 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-09 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Eingeleitet | BofA/Merrill | Underperform |
| 2019-03-27 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Eingeleitet | Jefferies | Underperform |
| 2019-01-18 | Eingeleitet | CIBC | Sector Outperform |
Alle ansehen
Cronos Group Inc Aktie (CRON) Neueste Nachrichten
Cronos Group (NASDAQ:CRON) Stock Rating Lowered by Wall Street Zen - marketbeat.com
Trulieve Cannabis (NYSE:TRUL) Climbs Into Spotlight As Sector Sentiment Shifts - Kalkine Media
Why Cronos Group Inc. (NASDAQ:CRON) Is Back In Focus? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) In Focus as Cannabis Rules Evolve Worth Watching? - Kalkine Media
Cronos (CRON) Q2 2026 Earnings Call Transcript - The Globe and Mail
Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch
Could Cronos Group (TSX:CRON) Be Canada’s Next Growth Stock? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) on Watch as Dow Trades Mixed? - Kalkine Media
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group (NASDAQ:CRON) the Cannabis Name Drawing Notice This Season - Kalkine Media
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Why Trump Media Stock Just Sank 9.4% - The Motley Fool
Why Cronos Group (NASDAQ:CRON) Keeps Building Global Cannabis Brand Reach? - Kalkine Media
Cronos Group Inc. (NASDAQ:CRON): Can Stronger Operations Support Growth? - Kalkine Media
Cronos Group (CRON) Institutional Ownership 2026 $CRON - MarketBeat
Cronos Group (NASDAQ:CRON): Can Brand Demand Strengthen? - Kalkine Media
TSX Value Stock Estimates Featuring Cronos Group And 2 More - webull.com
Cronos Group (TSX:CRON) Is Up 6.4% After Swinging Back To Profit And Beating Q2 Expectations - webull.com
Cronos Group Inc. 8-K/A Filing Confirms Annual Say-on-Pay Votes for Shareholders - Minichart
Deferred share unit grant for Cronos Group Inc. (CRON) director Garnick - Stock Titan
Director grant at Cronos Group Inc. (CRON) adds deferred share units - Stock Titan
Cronos Group Inc. (CRON) director receives deferred share unit award - Stock Titan
Cronos Group (NASDAQ:CRON) Brand Growth & Market Expansion Update - Kalkine Media
Cronos Group Inc (CRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts (NASDAQ:CRON) - Seeking Alpha
Why Cronos Group (NASDAQ:CRON) Is The Talk Of The Cannabis Sector Today? - Kalkine Media
Cronos Group expands in Europe with strong Q2 g... - Pluang
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A - Seeking Alpha
Cronos Group Stock Surges 13.68% as Cannabis Market Optimism and International Growth Spark Investor Interest - kalkine.ca
Why Has Cronos Group (TSX:CRON) Regained Market Spotlight Again? - Kalkine Media
CRON SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Cronos Group Inc. (CRON) Stock Analysis: Navigating a 40% Revenue Growth with Investor Ratings in Focus - DirectorsTalk Interviews
Cronos Group (NASDAQ:CRON): What Should Readers Watch Around Friday’s New Company Catalyst? - Kalkine Media
Cronos Group Inc (CRON) (Q2 2026) Earnings Call Highlights: Reco - GuruFocus
Cronos Group Inc. Reports Strong Q2 2026 Financial Results: Earnings, Revenue & Comprehensive Income Highlights - Minichart
Why Cronos Group (TSX:CRON) Is Up 6.4% After Swinging To US$32 Million Quarterly Profit - Yahoo Finance
Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch
Cronos Group (TSX:CRON) Expands Global Cannabis Strategy With Financial Strength - Kalkine Media
Cronos Group Announces Strong Q2 2026 Financial Performance with Increased Revenue and Operating Profit - Kalkine Media
Cannabis Stocks To Watch NowAugust 6th - MarketBeat
Cronos Group Q2 Earnings Call Highlights - Yahoo Finance
Cronos Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Is Cronos Group Inc (CRON) Undervalued After Q2 Earnings Beat wi - GuruFocus
Cronos Group Shares Rise After Swing to Q2 Earnings, Higher Revenue - marketscreener.com
Cronos Group (NASDAQ:CRON) Shares Gap Up After Better-Than-Expected Earnings - marketbeat.com
Stocks in play: Cronos Group Inc. - barchart.com
Earnings call transcript: Cronos Group posts Q2 2026 beat, shares jump 13.2% - Investing.com
Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Cronos Group Reports Record Q2 2026 Revenue of $53 Million - StratCann
Cronos stock jumps after Q2 beat (CRON:NASDAQ) - Seeking Alpha
Earnings Flash (CRON) Cronos Group Inc. Reports Q2 Revenue $53.0M, vs. FactSet Est of $44.2M - marketscreener.com
Finanzdaten der Cronos Group Inc-Aktie (CRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
5.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):